Suppr超能文献

疗效、安全性和自付费用是患者选择银屑病治疗方法时最重要的因素。

Efficacy, Safety, and Out-of-pocket Costs are the Most Important Factors to Patients in Choosing a Psoriasis Therapy.

作者信息

Secrest Aaron M, Matinrazm Ali, Ferris Laura K

机构信息

Department of Dermatology, University of Utah, Salt Lake City, Utah;

Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania.

出版信息

J Clin Aesthet Dermatol. 2014 Dec;7(12):30-3.

Abstract

OBJECTIVE

To determine which factors (i.e., cost, efficacy, safety, and method of delivery) influence choice of psoriasis treatment by patients and how patients obtain information regarding treatment options.

DESIGN

Anonymous survey.

SETTING

Specialty Psoriasis Clinic at an academic dermatology department over a six-month period.

PARTICIPANTS

Convenience sample of 40 psoriasis patients.

MEASUREMENTS

Participant demographics, psoriasis treatment history, sources of information about treatment options, factors influencing treatment choices, and knowledge of treatment costs.

RESULTS

The mean (±SD) patient age and duration of psoriasis was 50 (±17) and 19 (±17) years, respectively. Factors influencing patient's choice of psoriasis treatment were, in order of importance: efficacy (90% very important), safety/side effects (65%), patient's own cost (53%), then total treatment cost (46%), frequency of use (37%), and method of medication delivery (i.e., topical, oral, or injection; 17%). Eighty percent of patients reported not knowing the total cost of any psoriasis treatments. The patient's dermatologist was identified as both the most important (90%) and the most influential (75%) source of information for selecting psoriasis treatments, with the internet being the second most important source.

CONCLUSION

Patients, in large measure, are unaware of the costs for different psoriasis treatments. Efficacy, safety, and out-of-pocket costs are the most important factors to patients in deciding on a psoriasis treatment.

摘要

目的

确定哪些因素(即成本、疗效、安全性和给药方式)会影响患者对银屑病治疗方法的选择,以及患者如何获取有关治疗方案的信息。

设计

匿名调查。

地点

在一所学术性皮肤科的银屑病专科诊所,为期六个月。

参与者

40名银屑病患者的便利样本。

测量指标

参与者的人口统计学信息、银屑病治疗史、治疗方案的信息来源、影响治疗选择的因素以及对治疗费用的了解情况。

结果

患者的平均(±标准差)年龄和银屑病病程分别为50(±17)岁和19(±17)年。影响患者选择银屑病治疗方法的因素,按重要性排序依次为:疗效(90%认为非常重要)、安全性/副作用(65%)、患者自身成本(53%)、然后是总治疗成本(46%)、使用频率(37%)和给药方式(即外用、口服或注射;17%)。80%的患者表示不知道任何银屑病治疗的总成本。患者的皮肤科医生被认为是选择银屑病治疗方法最重要(90%)且最具影响力(75%)的信息来源,互联网是第二重要的来源。

结论

在很大程度上,患者并不了解不同银屑病治疗方法的成本。疗效、安全性和自付成本是患者决定银屑病治疗方法时最重要的因素。

相似文献

2
Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis.
Dermatol Ther (Heidelb). 2017 Dec;7(4):463-483. doi: 10.1007/s13555-017-0205-2. Epub 2017 Oct 20.
3
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460.
4
The costs of psoriasis medications.
Dermatol Ther (Heidelb). 2013 Dec;3(2):169-77. doi: 10.1007/s13555-013-0040-z. Epub 2013 Dec 13.
7
Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes.
Arch Dermatol. 2011 Nov;147(11):1285-94. doi: 10.1001/archdermatol.2011.309.
8
Patient preference for biologic treatments of psoriasis in Japan.
J Dermatol. 2019 Jun;46(6):466-477. doi: 10.1111/1346-8138.14870. Epub 2019 Apr 15.
9
Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Int J Dermatol. 2013 Mar;52(3):314-22. doi: 10.1111/j.1365-4632.2011.05340.x.

引用本文的文献

1
Understanding Psoriasis Patient Preferences for Biologic Dosing Frequencies: Insights From a Patient Survey.
J Psoriasis Psoriatic Arthritis. 2025 Jun 2:24755303251345804. doi: 10.1177/24755303251345804.
2
Out-of-pocket costs for patients with psoriasis in an outpatient dermatology referral service.
An Bras Dermatol. 2021 May-Jun;96(3):295-300. doi: 10.1016/j.abd.2020.09.004. Epub 2021 Mar 7.

本文引用的文献

1
Support needed to involve psoriasis patients in treatment decisions: survey of dermatologists.
J Cutan Med Surg. 2011 Jul-Aug;15(4):192-200. doi: 10.2310/7750.2011.10067.
2
A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
Expert Opin Pharmacother. 2011 Sep;12(13):2041-54. doi: 10.1517/14656566.2011.590475. Epub 2011 Jul 8.
3
The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics.
Br J Dermatol. 2010 Jun;162(6):1324-9. doi: 10.1111/j.1365-2133.2010.09693.x. Epub 2010 Feb 15.
4
Recent trends in systemic psoriasis treatment costs.
Arch Dermatol. 2010 Jan;146(1):46-54. doi: 10.1001/archdermatol.2009.319.
5
Psoriasis: improving adherence to topical therapy.
J Am Acad Dermatol. 2008 Dec;59(6):1009-16. doi: 10.1016/j.jaad.2008.08.028. Epub 2008 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验